Cargando…
Optimization of the Lactam Side Chain of 7-Azaindenoisoquinoline Topoisomerase I Inhibitors and Mechanism of Action Studies in Cancer Cells
[Image: see text] Optimization of the lactam ω-aminoalkyl substituents in a series of 7-azaindenoisoquinolines resulted in new anticancer agents with improved Top1 inhibitory potencies and cancer cell cytotoxicities. The new compounds 14–17 and 19 exhibited mean graph midpoint cytotoxicity (GI(50))...
Autores principales: | Kiselev, Evgeny, Sooryakumar, Dhriti, Agama, Keli, Cushman, Mark, Pommier, Yves |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American
Chemical
Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3983387/ https://www.ncbi.nlm.nih.gov/pubmed/24502276 http://dx.doi.org/10.1021/jm401471v |
Ejemplares similares
-
Design, Synthesis, and Biological
Evaluation of O-2-Modified
Indenoisoquinolines as Dual Topoisomerase I–Tyrosyl-DNA Phosphodiesterase
I Inhibitors
por: Lv, Peng-Cheng, et al.
Publicado: (2014) -
Topoisomerase I (TOP1) dynamics: conformational transition from open to closed states
por: Takahashi, Diane T., et al.
Publicado: (2022) -
Synthesis and Biological Evaluation
of New Carbohydrate-Substituted
Indenoisoquinoline Topoisomerase I Inhibitors and Improved Syntheses
of the Experimental Anticancer Agents Indotecan (LMP400) and Indimitecan
(LMP776)
por: Beck, Daniel E., et al.
Publicado: (2014) -
Exploring DNA Topoisomerase I Ligand Space in Search of Novel Anticancer Agents
por: Drwal, Malgorzata N., et al.
Publicado: (2011) -
The antitumor activity of CYB-L10, a human topoisomerase IB catalytic inhibitor
por: Yu, Qian, et al.
Publicado: (2019)